Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$12.63 - $24.47 $3,157 - $6,117
250 New
250 $5,000
Q2 2022

Aug 04, 2022

SELL
$1.72 - $3.39 $24 - $47
-14 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$2.77 - $3.64 $38 - $50
14 New
14 $0
Q2 2019

Aug 12, 2019

SELL
$6.05 - $13.66 $484 - $1,092
-80 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$8.16 - $13.42 $652 - $1,073
80 New
80 $1,000

Others Institutions Holding CBAY

About CymaBay Therapeutics, Inc.


  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.